Development of a Clioquinol Nanocarrier as a New, Promising Option for the Treatment of Dermatomycosis

Development of a Clioquinol Nanocarrier as a New, Promising Option for the Treatment of Dermatomycosis

Dermatomycosis is a common fungal infection, and its treatment is limited by few antifungal agents. Clioquinol (CQ) is an antiparasitic agent that has been studied for new uses, such as antifungal and antiviral applications. CQ was incorporated into a lipid-based nanocarrier as a new, promising opti...

Full description

Bibliographic Details
Main Authors: Simone Jacobus Berlitz, Paula Reginatto, Gabriella da Rosa Monte Machado, Alexandre Meneghello Fuentefria, Fernando Dal Pont Morisso, Renata Vidor Contri, Irene Clemes Külkamp-Guerreiro
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Pharmaceutics
Subjects:
cutaneous diseases
clioquinol
nanotechnology
antifungal
dermatomycosis
Online Access:https://www.mdpi.com/1999-4923/15/2/531

Internet

https://www.mdpi.com/1999-4923/15/2/531

Similar Items